DTC Healthtech & Telemedicine in hormone health with 558% Growth and $300k MRR

Claim My Business
Security Type
Technology, Healthcare & Medical
Min Investment
Expected Close Date
April 30, 2023
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Key Deal Facts

🤒Hormone Imbalance is an epidemic affecting 84 million. Only 12% will find 🚀. $45B Industry
📈 Patent Pending AI Engine cut industry standard time to care by 76% and cost of care by 64%
👨🏽‍⚕️Experienced leadership team with multiple exits and experience scaling global healthcare brands
💵 4.2 million raised to date from founders and investors
🚀558% revenue growth in 2022,
995% Growth forecasted in 2023 (not guaranteed)
🙋🏽‍♂️Scalable Acquisition Model: 4 Month CAC Payback and 96% Subscription Retention Rate.
💰Subscription revenue model, exceeding $300,000/month and 59% Gross Margins
🌍 Now Nationwide in the US and expanding into 3 new countries in 2023.

Management Team / Advisory Board Bios

Joshua Host CEO, Co-Founder, Board MemberJoshua Host is a mission driven founder that has created over $200 million in enterprise value and exits. Josh is a servant leader dedicated to scaling purpose built teams with the objective of changing the world. MBA from Pepperdine., Dr. Nayan Patel Chief Clinical Officer, Co-FounderDr. Nayan Patel is an internationally-recognized scientist, consultant, and lecturer on regenerative medicine. Dr. Patel has served over 250k patients with hormone health plans. PharmD from USC., Dr. Ryan Jones Chief Medical Director, Co-FounderDr. Ryan Jones completed his medical education at UT Southwestern Medical School and subsequently focused his efforts on obtaining a broad base of clinical experience at multiple levels and stages of healthcare delivery., Rahula Kocher Chief Technology Officer, Co-FounderRahula Kochar has two decades of experience building award-winning healthcare technology platforms to improve patient outcomes.
Amount Raised : $114,600
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter